LATEST NEWS
The National Cancer Institute (NCI) has awarded Mayo Clinic (Rochester), in partnership with SOFIE, a five-year R01 clinical trial, "Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 [...]
LATEST NEWS
The National Cancer Institute (NCI) has awarded Mayo Clinic (Rochester), in partnership with SOFIE, a five-year R01 clinical trial, "Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 [...]